Watson medicine shows promise
From Times Wire Services
Watson Pharmaceuticals Inc.’s experimental drug for prostate enlargement reduced symptoms without significant blood pressure or heart side effects, the company said.
Silodosin, which Corona-based Watson intends to sell as Rapaflo, had “minimal effects” on blood pressure and heart rate during yearlong tests in people who took it alone or in combination with drugs to treat erectile dysfunction, the company said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
